Raleigh office will target healthcare work and is top 50 firm’s 23rd US base | 4mos
Life Sciences - Page 2
Glucose monitoring patent revoked across 17 UPC member states in ongoing dispute with rival Abbott | 4mos
Freshfields, Taylor Wessing and Powell Gilbert advise on closely watched London High Court dispute | 4mos
IP and disputes group’s move follows ArentFox Schiff adding automotive partner quartet from Burns in Boston in April | 5mos
Historic attitudes favouring globalisation are fundamentally changing. | 1yr
Team moves over from Lerner David strengthening medical device practice | 5mos
Decision upholds earlier ruling revoking patent covering the drug Xarelto, further clearing way for generic manufacturers to enter the lucrative market | 5mos
.jpg)
Tobias Knapp joins as co-head of global firm’s New York transactional group | 5mos
.jpg)
Covington counsels Biogen as Goodwin reps acquisition target Human Immunobiology Biosciences | 5mos
.jpg)
Former FDA lawyers Jennifer Bragg and William McConagha move over in DC as Safehold CLO Douglas Heitner joins real estate team in New York | 5mos
.jpg)
Office to handle outbound work for Japanese clients as UK firm aims to reach €1bn revenue in five years | 6mos
Led by respected life sciences litigator Siegmund Gutman, the team of 10 move over from Proskauer Rose | 6mos
.jpg)
Düsseldorf local division orders US life sciences company Curio Bioscience to stop selling its products in Germany, France and Sweden in dispute with rival 10x Genomics | 6mos
Transatlantic merger creates global giant with nearly 4,000 lawyers and $3.5bn revenue | 6mos
UK pharmaceutical firm enters the fray in the battle over mRNA technology used to develop blockbuster vaccines | 6mos
.jpg)
Greenberg counsels Ono in deal to expand Japanese group’s oncology portfolio and US presence | 6mos
.jpg)
Women make up majority of round for firm in strong growth mode | 6mos
Irena Royzman is fourth IP partner to join tech-focused firm this year | 7mos
.jpg)
John Godfrey is the 12th Paul Weiss lawyer to decamp to Sidley in past 10 months | 7mos
.jpg)
Deal second this month to see Freshfields advise acquisitive AstraZeneca | 7mos
.jpg)
Tech-focused firm sees PEP grow 8.2% following almost 20% decline in 2022 | 8mos
Copyright 2024 © The Global Legal Post. All Rights Reserved